
Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities
As pharma manufacturers prioritize US supply chain resilience, highlights include high-speed isolator filling lines








